Global Biotech Stocks

NeoImmuneTech

Market Cap: ₩74.4b

A clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics.

Noile-Immune Biotech

Market Cap: JP¥7.8b

Researches and develops CAR-T cells for cancer immunotherapies.

Imugene

Market Cap: AU$79.9m

A clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.

UBI Pharma

Market Cap: NT$1.7b

UBI Pharma Inc. develops, manufactures, and sells pharmaceutical products in Taiwan.

INmune Bio

Market Cap: US$51.8m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

Earth Science Tech

Market Cap: US$51.2m

Together with its subsidies, focuses on health and wellness industry.

Navana Pharmaceuticals

Market Cap: ৳6.2b

Engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh.

Psomagen

Market Cap: ₩71.6b

Engages in the provision omics solutions and contract laboratory services.

Veru

Market Cap: US$50.5m

A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).

Actinium Pharmaceuticals

Market Cap: US$50.5m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Medical Developments International

Market Cap: AU$76.6m

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.

PDS Biotechnology

Market Cap: US$49.8m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.

Rafael Holdings

Market Cap: US$49.5m

Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel.

Cantourage Group

Market Cap: €42.4m

Operates as a medical cannabis company in Europe.

Sinil Pharmaceutical

Market Cap: ₩69.6b

Manufactures and sells pharmaceutical products in South Korea and internationally.

Acrivon Therapeutics

Market Cap: US$49.1m

A clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.

Inotiv

Market Cap: US$48.8m

Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

Ark Solutions

Market Cap: ₩68.9b

Engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally.

Jin Yang Pharmaceutical

Market Cap: ₩68.2b

Engages in the pharmaceutical business in South Korea.

Hyperion DeFi

Market Cap: US$48.2m

An ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.

GENINUS

Market Cap: ₩67.9b

A bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea.

Barinthus Biotherapeutics

Market Cap: US$48.0m

A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.

TMS

Market Cap: JP¥7.1b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

Yuyu Pharma

Market Cap: ₩66.9b

Develops and markets pharmaceutical products.

Kim Forest Enterprise

Market Cap: NT$1.4b

Provides various genetic and medical testing services in China and the United States.

October PharmaE

Market Cap: ج.م2.2b

Manufactures and sells pharmaceutical products in Egypt.

Tianda Pharmaceuticals

Market Cap: HK$361.2m

Engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.

Influx Healthtech

Market Cap: ₹4.1b

Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.

Cumberland Pharmaceuticals

Market Cap: US$45.3m

A specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally.

Radiopharm Theranostics

Market Cap: AU$68.6m

A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret

Market Cap: ₺1.9b

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.

Korea Arlico PharmLtd

Market Cap: ₩62.8b

Engages in the researches and develops, produces, and sells medicines in South Korea.

Central Pharmaceutical No3

Market Cap: ₫1.2t

Engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally.

CalciMedica

Market Cap: US$43.7m

A clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage.

WDB coco

Market Cap: JP¥6.5b

Provides contract services to pharmaceutical companies in Japan.

Arecor Therapeutics

Market Cap: UK£32.7m

A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.